820
Views
49
CrossRef citations to date
0
Altmetric
Original Article

Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: Trouble at the borders

, &
Pages 9-19 | Published online: 11 Jul 2009

References

  • Addington, A. M., Gomick, M., Sporn, A. L., Gogtay, N., Greenstein, D., Lenane, M., et al. (2004). Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biological Psychiatry, 55, 976–980.
  • Ahlfors, U. G., Baastrup, P. C., Dencker, S. J., Elgen, K., Lingjaerde, 0., Pedersen, V., et al. (1981). Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium. Acta Psychiatrica Scandinavica, 64, 226–237.
  • Badner, J. A., & Gershon, E. S. (2002). Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Molecular Psychiatry, 7, 405–411.
  • Basan, A., & Leucht, S. (2004). Valproate for schizophrenia. Cochrane Database System Rev, CD004028.
  • Berrettini, W. H. (2000). Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biological Psychiatry, 48, 531–538.
  • Berrettini, W. H., Ferraro, T. N., Goldin, L. R., Weeks, D. E., Detera-Wadleigh, S., Numberger, J. I. J., et al. (1994). Chromosome 18 DNA markers and manic-depressive illness: Evidence for a susceptibility gene. Proceedings of the National Academy of Science USA, 91, 5918–5921.
  • Black, D. W., & Nasrallah, A. (1989). Hallucinations and delusions in 1715 patients with unipolar and bipolar affective disorders. Psychopathology, 22, 28–34.
  • Blouin, J. L., Dombroski, B. A., Nath, S. K., Lasseter, V. K., Wolyniec, P. S., Nestadt, G., et al. (1998). Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nature Genetics, 20, 70–73.
  • Brzustowicz, L. M., Honer, W. G., Chow, E. W., Little, D., Hogan, J., Hodgkinson, K., et al. (1999). Linkage of familial schizophrenia to chromosome 13q32. American Journal of Human Genetics, 65, 1096–1103.
  • Burch Jr., E. A., Anton, R. F., & Carson, W. H. (1994). Mood congruent and incongruent psychotic depressions: Are they the same? Journal of Affective Disorders, 31, 275–280.
  • Cardno, A. G., Rijsdijk, F. V., Sham, P. C., Murray, R. M., SE McGuffm, P. (2002). A twin study of genetic relationships between psychotic symptoms. American Journal of Psychiatry, 159, 539–545.
  • Carpenter, W. T. J., Strauss, J. S., & Muleh, S. (1973). Are there pathognomonic symptoms in schizophrenia? An empiric inves-tigation of Schneider's first-rank symptoms. Archives in General Psychiatry, 28, 847–852.
  • Chen, Y. S., Akula, N., Detera-Wadleigh, S. D., Schulze, T. G., Thomas, J., Potash, J. B., et al. (2004). Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33. Molecular Psychiatry, 9,87–92.
  • Chumakov, I., Blumenfeld, M., Guerassimenko, 0., Cavarec, L., Palicio, M., Abderrahim, H., et al. (2002). Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proceedings of the National Academy of Science USA, 99,13675–13680.
  • Citrome, L., Jaffe, A., Levine, J., & Allingharn, B. (2002). Use of mood stabilizers among patients with schizophrenia, 1994-2001. Psychiatric Services, 53, 1212.
  • DeLisi, L. E., Goldin, L. R., Maxwell, M. E., Kazuba, D. M., SE Gershon, E. S. (1987). Clinical features of illness in siblings with schizophrenia or schizoaffective disorder. Archives in General Psychiatry, 44, 891–896.
  • Detera-Wadleigh, S. D., Badner, J. A., Berrettini, W. H., Yoshikawa, T., Goldin, L. R., Turner, G., et al. (1999). A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proceedings of the National Academy of Science USA, 96,5604–5609.
  • Drevets, W. C., Price, J. L., Simpson Jr., J. R., Todd, R. D., Reich, T., Vannier, M., et al. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature, 386, 824–827.
  • Elkis, H., Friedman, L., Wise, A., & Meltzer, H. Y. (1995). Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia. Archives in General Psychiatry, 52, 735–746.
  • Erlenmeyer-Kimling, L., Adamo, U. H., Rock, D., Roberts, S. A., Bassett, A. S., Squires-Wheeler, E., et al. (1997). The New York High-Risk Project. Prevalence and comorbidity of axis I disorders in offspring of schizophrenic parents at 25-year follow-up. Archives in General Psychiatry, 54, 1096–1102.
  • Ertugrul, A., & Meltzer, H. Y. (2003). Antipsychotic drugs in bipolar disorder. International Journal of Neuropsychopharma-cology., 6,277–284.
  • Esparon, J., Kolloori, J., Naylor, G. J., Mcharg, A. M., Smith, A. H., & Hopwood, S. E. (1986). Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. British Journal of Psychiatry, 148, 723–725.
  • Faraone, S. V., Blehar, M., Pepple, J., Moldin, S. 0., Norton, J., Nurnberger, J. I., et al. (1996). Diagnostic accuracy and confusability analyses: An application to the Diagnostic Inter-view for Genetic Studies. Psychological Medicine, 26, 401–410.
  • Faraone, S. V., Matise, T., Svrakic, D., Pepple, J., Malaspina, D., Suarez, B., et al. (1998). Genome scan of European-American schizophrenia pedigrees: Results of the NIMH Genetics Initiative and Millennium Consortium. American Journal of Medical Genetics, 81, 290–295.
  • Farmer, A. E., McGuffin, P., & Gottesman, I. I. (1987). Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition. Archives in General Psychiatry, 44, 634–641.
  • Fennig, S., Bromet, E. J., Karant, M. T., Ram, R., & Jandorf, L. (1996). Mood-congruent versus mood-incongruent psychotic symptoms in first-admission patients with affective disorder. Journal of Affective Disorders, 37,23–29.
  • Foroud, T., Castelluccio, P. F., Koller, D. L., Edenberg, H. J., Miller, M., Bowman, E., et al. (2000). Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees. American Journal of Medical Genetics, 96,18–23.
  • Forrester, A., Owens, D. G., & Johnstone, E. C. (2001). Diagnostic stability in subjects with multiple admissions for psychotic illness. Psychological Medicine, 31, 151–158.
  • Gershon, E. S., Delisi, L. E., Harnovit, J., Nurnberger, J. I. J., Maxwell, M. E., Schreiber, J., et al. (1988). A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder. Archives in General Psychiatry, 45, 328–336.
  • Gershon, E. S., Hamovit, J., Guroff, J. J., Dibble, E., Leckman, J. F., Sceery, W., et al. (1982). A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Archives in General Psychiatry, 39,1157–1167.
  • Gill, M., Vallada, H., Collier, D., Sham, P., Holmans, P., Murray, R., et al. (1996). A combined analysis of D225278 marker alleles in affected sib-pairs: Support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). American Journal of Medical Genetics, 67,40–45.
  • Goodwin, F. K., & Jamison, K. R. (1990). Manic-Depressive Illness. New York: Oxford University Press.
  • Guidotti, A., Auta, J., Davis, J. M., Gerevini, V. D., Dwivedi, Y., Grayson, D. R., et al. (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study. Archives in General Psychiatry, 57, 1061–1069.
  • Harrison, P. J. (2002). The neuropathology of primary mood disorder. Brain, 125, 1428–1449.
  • Harrow, M., Grossman, L. S., Herbener, E. S., & Davies, E. W. (2000). Ten-year outcome: Patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. British Journal of Psychiatry, 177, 421–426.
  • Hattori, E., Liu, C., Badner, J. A., Bonner, T. I., Christian, S. L., Maheshwari, M., et al. (2003). Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. American Journal of Human Genetics, 72, 1131–1140.
  • Heila, H., Isometsa, E. T., Henriksson, M. M., Heikkinen, M. E., Marttunen, M. J., & Lonnqvist, J. K. (1997). Suicide and schizophrenia: A nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. American Journal of Psychiatry, 154, 1235–1242.
  • Hirayasu, Y., Shenton, M. E., Salisbury, D. F., Dickey, C. C., Fischer, I. A., Mazzoni, P., et al. (1998). Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. American Journal of Psychiatry, 155, 1384–1391.
  • Hirayasu, Y., Shenton, M. E., Salisbury, D. F., Kwon, J. S., Wible, C. G., Fischer, I. A., et al. (1999). Subgenual cingulate cortex volume in first-episode psychosis. American Journal of Psychiatry, 156, 1091–1093.
  • Hodgkinson, C. A., Goldman, D., Jaeger, J., Persaud, S., Kane, J. M., Lipsky, R. H., et al. (2004). Disrupted in Schizophrenia 1 (DISC 1): Association with schizophrenia, schizoaffective disorder, and bipolar disorder. American Journal of Human Genetics, 75, 862–872.
  • Jablensky, A., Hugler, H., Von, C. M., & Kalinov, K. (1993). Kraepelin revisited: A reassessment and statistical analysis of dementia praecox and manic-depressive insanity in 1908. Psychological Medicine, 23, 843–858.
  • Johnson, D. A. (1988). The significance of depression in the prediction of relapse in chronic schizophrenia. British Journal of Psychiatry, 152, 320–323.
  • Jorgensen, P., & Mortensen, P. B. (1988). Admission pattern and diagnostic stability of patients with functional psychoses in Denmark during a two-year observation period. Acta Psychiatrica Scandinavica., 78, 361–365.
  • Kasai, K., Shenton, M. E., Salisbury, D. F., Onitsuka, T., Toner, S. K., Yurgelun-Todd, D., et al. (2003). Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affec-tive psychosis. Archives in General Psychiatry, 60, 1069–1077.
  • Kasanin, J. (1933). The acute schizoaffective psychoses. American Journal of Psychiatry, 90, 97–126.
  • Kelsoe, J. R., Spence, M. A., Loetscher, E., Foguet, M., Sadomick, A. D., Remick, R. A., et al. (2001). A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proceedings of the National Academy of Science USA, 98, 585–590.
  • Kendell, R. E. (1974). The stability of psychiatric diagnosis. British Journal of Psychiatry, 124, 352–356.
  • Kendler, K. S. (1991). Mood-incongruent psychotic affective illness. A historical and empirical review. Archives in General Psychiatry, 48, 362–369.
  • Kendler, K. S., Gruenberg, A. M., & Tsuang, M. T. (1985). Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. A family study using DSM-III criteria. Archives in General Psychiatry, 42, 770–779.
  • Kendler, K. S., Gruenberg, A. M., & Tsuang, M. T. (1986). A DSM-III family study of the non-schizophrenic psychotic disorders. American Journal of Psychiatry, 143, 1098–1105.
  • Kendler, K. S., Karkowski-Shuman, L., O'Neill, F. A., Straub, R. E., Maclean, C. J., & Walsh, D. (1997). Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of High-Density Schizophrenia Families: Evidence for possible etiologic heterogeneity. American Journal of Psychiatry, 154, 191–198.
  • Kendler, K. S., McGuire, M., Gruenberg, A. M., O'Hare, A., Spellman, M., & Walsh, D. (1993a). The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Archives in General Psychiatry, 50, 527–540.
  • Kendler, K. S., McGuire, M., Gruenberg, A. M., O'Hare, A., Spellman, M., & Walsh, D. (1993b). The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives. Archives in General Psychiatry, 50, 952–960.
  • Koh, P. 0., Undie, A. S., Kabbani, N., Levenson, R., Goldman-Rakic, P. S., & Lidow, M. S. (2003). Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizo-phrenic and bipolar patients. Proceedings of the National Academy of Science USA, 100, 313–317.
  • Korostishevsky, M., Kaganovich, M., Cholostoy, A., Ashkenazi, M., Ratner, Y., Dahary, D., et al. (2004). Is the G72/G30 locus associated with schizophrenia? Single nucleo-tide polymorphisms, haplotypes, and gene expression analysis. Biological Psychiatry, 56, 169–176.
  • Kraepelin, E. (1899). Manic-depressive insanity and paranoia.
  • Lehmann, H. E., & Hanrahan, G. E. (1954). Chlorpromazine; new inhibiting agent for psychomotor excitement and manic states. American Medical Association, Archives in Neurology & Psychiatry, 71, 227–237.
  • Leucht, S., Kissling, W., & McGrath, J. (2004). Lithium for schizophrenia revisited: A systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Psychiatry, 65, 177–186.
  • Leucht, S., McGrath, J., White, P., & Kissling, W. (2002). Carbarnazepine for schizophrenia and schizoaffective psychoses. Cochrane Database System Rev, CD001258.
  • Lin, M. W., Sham, P., Hwu, H. G., Collier, D., Murray, R., & Powell, J. F. (1997). Suggestive evidence for linkage of schizophrenia to markers on chromosome 13 in Caucasian but not Oriental populations. Human Genetics, 99,417–420.
  • Littlejohn, R, Leslie, F., & Cookson, J. (1994). Depot anti-psychotics in the prophylaxis of bipolar affective disorder. British Journal of Psychiatry, 165, 827–829.
  • Maier, W., Lichtermann, D., Minges, J., Hallmayer, J., Heun, R., Benkert, 0., & Levinson, D. F. (1993). Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Archives in General Psychiatry, 50, 871–883.
  • Maj, M., Pirozzi, R., Formicola, A. M., Bartoli, L., SE Bucci, P. (2000). Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: Preliminary data. Journal of Affective Disorders, 57, 95–98.
  • Marneros, A., Deister, A., & Rohde, A. (1991). Stability of diagnoses in affective, schizoaffective and schizophrenic dis-orders. Cross-sectional versus longitudinal diagnosis. European Archives in Psychiatry & Clinical Neuroscience, 241, 187–192.
  • Maziade, M., Roy, M. A., Martinez, M., Cliche, D., Fournier, J. P., Garneau, Y., et al. (1995). Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: Continuity and discontinuity between the major psychoses. American Journal of Psychiatry, 152, 1458–1463.
  • McDonald, C., Bullmore, E. T., Sham, P. C., Chitnis, X., Wickham, H., Brarnon, E., et al. (2004). Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Archives in General Psychiatry, 61, 974–984.
  • McHugh, P. R., SE Slavney, P. R. (1998). The Perspectives of Psychiatry (Second Edition). Baltimore: Johns Hopkins University Press.
  • McIntosh, A. M., Forrester, A., Lawrie, S. M., Byrne, M., Harper, A., Kestelman, J. N., et al. (2001). A factor model of the functional psychoses and the relationship of factors to clinical variables and brain morphology. Psychological Medicine, 31, 159–171.
  • Nothen, M. M., Cichon, S., Rohleder, H., Hemmer, S., Franzek, E., Fritze, J., et al. (1999). Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Molecular Psychiatry, 4, 76–84.
  • Omahony, E., Corvin, A., O'Connell, R., Comerford, C., Larsen, B., Jones, R., et al. (2002). Sibling pairs with affective disorders: Resemblance of demographic and clinical features. Psychological Medicine, 32, 55–61.
  • Ozeki, Y., Tomoda, T., Kleiderlein, J., Kamiya, A., Bord, L., Fujii, K., et al. (2003). Disrupted-in-Schizophrenia-1 (DISC-I): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proceedings of the National Academy of Science USA, 100, 289–294.
  • Pearlson, G. D., Wong, D. F., Tune, L. E., Ross, C. A., Chase, G. A., Links, J. M., et al. (1995). In vivo D2 dopamine receptor density in psychotic and non-psychotic patients with bipolar disorder. Archives in General Psychiatry, 52, 471–477.
  • Plum, F. (1972). Prospects for research on schizophrenia. 3. Neurophysiology. Neuropathological findings. Neuroscience Research Programs Bulletin, 10, 384–388.
  • Pope Jr., H. G., & Lipinski, J. F., Jr. (1978). Diagnosis in schizophrenia and manic-depressive illness: A reassessment of the specificity of 'schizophrenic' symptoms in the light of current research. Archives in General Psychiatry, 35, 811–828.
  • Potash, J. B., Chiu, Y. F., MacKinnon, D. F., Miller, E. B., Simpson, S. G., McMahon, F. J., et al. (2003a). Familial aggregation of psychotic symptoms in a replication set of 69 bipolar disorder pedigrees. American Journal of Medical Genetics, 160, 680–686.
  • Potash, J. B., Zandi, P. P., Wilbur, V. L., Lan, T. H., Huo, Y., Avramopoulos, D., et al. (2003b). Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. American Journal of Psychiatry, 160, 680–686.
  • Potash, J. B., Wilbur, V. L., Chiu, Y.-F., Simpson, S. G., MacKinnon, D. F., Pearlson, G. D., et al. (2001). The familial aggregation of psychotic symptoms in bipolar disorder pedigrees. American Journal of Psychiatry, 158, 1258–1264.
  • Pulver, A. E., Mulle, J., Nestadt, G., Swartz, K. L., Blouin, J.-L., Dombroski, B., et al. (2000). Genetic heterogeneity in schizophrenia: Stratification of genome scan data using co-segregating related phenotypes. Molecular Psychiatry, 5, 650–653.
  • Ratakonda, S., Gorman, J. M., Yale, S. A., & Amador, X. F. (1998). Characterization of psychotic conditions. Use of the domains of psychopathology model. Archives in General Psychiatry, 55, 75–81.
  • Rounsaville, B. J., Alarcon, R. D., Andrews, G., Jackson, J. S., Kendell, R. E., SE Kendler, K. (2002). Basic nomenclature issues for DSM-V. 1–29.
  • Sachs, G. S., Grossman, F., Ghaemi, S. N., Okamoto, A., & Bowden, C. L. (2002). Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: A double-blind, placebo-controlled comparison of efficacy and safety. American Journal of Psychiatry, 159, 1146–1154.
  • Salokangas, R. K., Cannon, T., Van, E. T., Ilonen, T., Taiminen, T., Karlsson, H., et al. (2002). Structural magnetic resonance imaging in patients with first-episode schizophrenia, psychotic and severe non-psychotic depression and healthy controls. Results of the schizophrenia and affective psychoses (SAP) project. British Journal of Psychiatry, 43(Suppl), s58–s65.
  • Schizophrenia Collaborative Linkage Group For Chromosome 22. (1998). A transmission disequilibrium and linkage analysis of D225278 marker alleles in 574 families: Further support for a susceptibility locus for schizophrenia at 22q12. Schizophrenia Research, 32, 115–121.
  • Schneider, K., & (transl. M. W. Hamilton) (1959). Clinical Psychopathology. New York: Grune and Stratton.
  • Schumacher, J., Jamra, R. A., Freudenberg, J., Becker, T., Ohlraun, S., One, A. C., et al. (2004). Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizo-phrenia and bipolar affective disorder. Molecular Psychiatry, 9, 203–207.
  • Schurhoff, F., Szoke, A., Meary, A., Bellivier, F., Rouillon, F., Pauis, D., et al. (2003). Familial aggregation of delusional proneness in schizophrenia and bipolar pedigrees. American Journal of Psychiatry, 160, 1313–1319.
  • Schwab, S. G., Hallmayer, J., Albus, M., Lerer, B., Eckstein, G. N., Boimiann, M., et al. (2000). A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: Support for loci on chromosome 10p and 6. Molecular Psychiatry, 5, 638–649.
  • Schwab, S. G., Hallmayer, J., Lerer, B., Albus, M., Borrmann, M., Honig, S., et al. (1998). Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. American Journal of Human Genetics, 63,1139–1152.
  • Schwartz, J. E., Fennig, S., Tanenberg-Karant, M., Carlson, G., Craig, T., Galambos, N., et al. (2000). Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Archives in General Psychiatry, 57, 593–600.
  • Sham, P. C., Castle, D. J., Wessely, S., Farmer, A. E., & Murray, R. M. (1996). Further exploration of a latent class typology of schizophrenia. Schizophrenia Research, 20, 105–115.
  • Sham, P. C., Maclean, C. J., & Kendler, K. S. (1994). A typological model of schizophrenia based on age at onset, sex and familial morbidity. Acta Psychiatrica Scandinavica, 89, 135–141.
  • Sins, S. G. (2000). Depression in schizophrenia: Perspective in the era of 'Atypical' anti-psychotic agents. American Journal of Psychiatry, 157, 1379–1389.
  • Spiker, D. G., Weiss, J. C., Dealy, R S., Griffin, S. J., Hanin, I., Neil, J. F., et al. (1985). The pharmacological treatment of delusional depression. American Journal of Psychiatry, 142, 430–436.
  • Stine, 0. C., Xu, J., Koskela, R., McMahon, F. J., Gschwend, M., Friddle, C., et al. (1995). Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. American Journal of Human Genetics, 57, 1384–1394.
  • Strakowski, S. M., Delbello, M. P., Sax, K. W., Zimmerman, M. E., Shear, P. K., Hawkins, J. M., et al. (1999). Brain
  • magnetic resonance imaging of structural abnormalities in bipolar disorder. Archives in General Psychiatry, 56,254–260.
  • Straub, R. E., Maclean, C. J., Martin, R. B., Ma, Y., Myakishev, M. V., Harris-Kerr, C., et al. (1998). A schizo-phrenia locus may be located in region 10p15-p11. American Journal of Medical Genetics, 81, 296–301.
  • Suppes, T., Webb, A., Paul, B., Carmody, T., Kraemer, H., & Rush, A. J. (1999). Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. American Journal of Psychiatry, 156, 1164–1169.
  • Tohen, M., Chengappa, K. N., Suppes, T., Baker, R. W., Zarate, C. A., Bowden, C. L., et al. (2004). Relapse preven-tion in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser versus mood stabiliser alone. British Journal of Psychiatry, 184, 337–345.
  • Tohen, M., Tsuang, M. T., & Goodwin, D. C. (1992). Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features. American Journal of Psychiatry, 149, 1580–1584.
  • Tremolizzo, L., Carboni, G., Ruzicka, W. B., Mitchell, C. P., Sugaya, I., Tueting, P., et al. (2002). An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proceedings of the National Academy of Science USA, 99,17095–17100.
  • Tsuang, M. T., Woolson, R. F., Winokur, G., & Crowe, R. R. (1981). Stability of psychiatric diagnosis. Schizophrenia and affective disorders followed up over a 30- to 40-year period. Archives in General Psychiatry, 38, 535–539.
  • Vaillant, G. E. (1964). Prospective prediction of schizophrenic remission. Archives in General Psychiatry, 11, 509–518.
  • Van, 0. J., Gilvarry, C., Bale, R., Van, H. E., Tattan, T., White, I., et al. (1999). A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychological Medicine, 29, 595–606.
  • Vawter, M. P., Thatcher, L., Usen, N., Hyde, T. M., Kleinman, J. E., & Freed, W. J. (2002). Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Molecular Psychiatry, 7, 571–578.
  • Wang, X., He, G., Gu, N., Yang, J., Tang, J., Chen, Q., et al. (2004). Association of G72/G30 with schizophrenia in the Chinese population. Biochemistry & Biophysics Research Communications, 319, 1281–1286.
  • White, E., Cheung, P., & Silverstone, T. (1993). Depot anti-psychotics in bipolar affective disorder. International Clinical Psychopharmacology, 8, 119–122.
  • Whitehead, C., Moss, S., Cardno, A., & Lewis, G. (2003). Antidepressants for the treatment of depression in people with schizophrenia: A systematic review. Psychological Medicine, 33, 589–599.
  • Zarate Jr, C. A., (2000). Anti-psychotic drug side effect issues in bipolar manic patients. Journal of Clinical Psychiatry, 6/ (Suppl. 8), 52–61 and discussion 62–63.
  • Zarate Jr, C. A., & Tohen, M. (2004). Double-blind comparison of the continued use of anti-psychotic treatment versus its discontinuation in remitted manic patients. American Journal of Psychiatry, 161, 169–171.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.